The patient may report an olfactory disorder, pain with mastication, toothache and fever. The symptoms of chronic sinusitis, tend to be more vague and poorly localized. In both types of sinusitis ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA broadened dupilumab's (Dupixent) approval as an add ...

compared to placebo in SINUS-24 and SINUS-52 (24-week safety pool) were injection site reactions, eosinophilia, insomnia, toothache, gastritis, arthralgia and conjunctivitis. About Dupixent ...

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNP Current treatment options leave many patients with uncontrolled disease and ...

toothache and fatigue. Failure to seek treatment for sinusitis will result in unnecessary pain and discomfort. In rare cases, meningitis or brain abscess and infection of the bone or bone marrow ...

The approval is based on results from two pivotal adult trials, SINUS-24 and SINUS-52 ... eosinophilia, insomnia, toothache, gastritis, arthralgia, and conjunctivitis. Regeneron and Sanofi ...

Expenses on education, vehicle, property, or tourism. Career: Beneficial for education, automobile, property, tourism, ...

The label expansion provides a new option for the hundreds of thousands of Americans with inadequately controlled COPD.